微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.63% | -9.93% | -52.01% | 28/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 5.48% | -27.42% | -19.29% | 32/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 6.79% | -25.63% | 65.61% | 26/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.1% | -22.2% | 40.41% | 30/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.92% | -6.71% | -61.32% | 25/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 7.55% | -17.12% | -17.31% | 32/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 9.13% | 10.27% | 73.24% | 21/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.27% | 3.54% | 68.37% | 27/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 3.13% | 7.93% | -65.64% | 32/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 9.11% | -22.27% | 10.02% | 27/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 8.28% | -16.95% | 62.67% | 26/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 5.09% | -17.37% | 75.52% | 25/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.9% | -1.69% | -75.26% | 26/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 11.72% | -10.33% | 17.55% | 20/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 9.97% | 3.85% | 61.85% | 20/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 6.16% | -0.16% | 108.81% | 19/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.95% | 10.07% | -77.43% | 24/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 13.07% | -11.15% | 36.15% | 11/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 9.6% | -22.08% | 55.59% | 21/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 6.17% | -30.6% | 130.22% | 15/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.68% | -34.95% | -81.78% | 20/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 14.71% | -4.54% | 19.4% | 9/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 12.32% | -0.73% | 38.58% | 6/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 8.89% | 14.56% | 115.78% | 7/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 4.12% | 18.39% | -73.26% | 13/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 15.41% | 21.24% | 24.17% | 11/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 12.41% | 40.7% | 59.92% | 9/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.76% | 39.32% | 122.99% | 12/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 3.48% | 22.54% | -72.62% | 21/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 12.71% | -4.58% | 44.1% | 20/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 8.82% | -17.72% | 58.35% | 28/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 5.57% | -20.66% | 96.13% | 30/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.84% | -33.33% | -78.68% | 27/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 13.32% | -18.88% | 24.25% | 22/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 10.72% | -12.35% | 52.71% | 20/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 7.02% | -6.77% | 64.79% | 23/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 4.26% | 19.33% | -74.06% | 13/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 16.42% | 16.12% | 34.26% | 17/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 12.23% | 17.71% | 62.42% | 14/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 7.53% | 14.79% | 110.92% | 22/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 3.57% | 25.26% | -74.75% | 24/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |